Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives
Elmentve itt :
Szerzők: |
Stanković Tijana Dankó Balázs Martins Ana Dragoj Miodrag Stojiljković Sonja Isaković Aleksandra Wang Hui-Chun Wu Yang-Chang Hunyadi Attila Pesić Milica |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2015
|
Sorozat: | CANCER CHEMOTHERAPY AND PHARMACOLOGY
76 No. 3 |
doi: | 10.1007/s00280-015-2821-9 |
mtmt: | 2935089 |
Online Access: | http://publicatio.bibl.u-szeged.hu/6684 |
Hasonló tételek
-
Protoflavones a class of unusual flavonoids as promising novel anticancer agents /
Szerző: Hunyadi Attila, et al.
Megjelent: (2014) -
In vitro cytotoxic activity of novel protoflavone analogs – selectivity towards a multidrug resistant cancer cell line
Szerző: Dankó Balázs Ödön, et al.
Megjelent: (2012) -
Collateral sensitivity An evolutionary trade-off between antibiotic resistance mechanisms, attractive for dealing with drug-resistance crisis /
Szerző: Yekani Mina, et al.
Megjelent: (2023) -
Synthesis and SAR study of anticancer protoflavone derivatives investigation of cytotoxicity and interaction with ABCB1 and ABCG2 multidrug efflux transporters /
Szerző: Dankó Balázs, et al.
Megjelent: (2017) -
Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides—A Review
Szerző: Fodor András, et al.
Megjelent: (2020)